Composition: Gatifloxacin 0.3% w/v + Flurbiprofen 0.03% w/v
Formulation: Eye Drops
Category: Antibiotic + NSAID
Packaging: 5ML



Therapy/Class: Antibiotic + NSAID
Mechanism of Action:
Gatifloxacin: An 8-methoxy fluoroquinolone characterized by dual-target inhibition of bacterial DNA gyrase and Topoisomerase IV. It demonstrates excellent corneal penetration and broad-spectrum coverage, effectively eradicating common conjunctival and corneal isolates.
Flurbiprofen: An NSAID that actively blocks the cyclooxygenase enzyme system. It is clinically utilized to preserve intraoperative mydriasis by inhibiting surgically-induced prostaglandin synthesis in the iris sphincter.
Treatment of bacterial conjunctivitis caused by susceptible organisms
Superficial ocular bacterial infections as advised by the treating ophthalmologist
Note: This is an indicative Indication, please follow the doctors advise. Do not self medicate.
Instill 1 drop into the inferior conjunctival cul-de-sac of the affected eye(s) as prescribed by the physician. Dosing frequency should be adjusted according to clinical response and severity.
Note: This is an indicative dosage, please follow the doctors advise. Do not self medicate.
1. Perry HD, et al. Gatifloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis. Ophthalmology. 2005;112(1):86-90.
2. Mather R, et al. The susceptibility of ocular pathogens to gatifloxacin and other fluoroquinolones. Am J Ophthalmol. 2002;133(4):463-466.
1. Keates RH, et al. Clinical trial of flurbiprofen to maintain pupillary dilation during cataract surgery. Ann Ophthalmol. 1984;16(10):919-921.
Warning: This information is only for the use of registered medical practitioners only.
Error: Contact form not found.
